These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 353727)

  • 1. [Pseudo-lymphomas and lymphomas induced by hydantoins].
    Reiffers J
    Nouv Rev Fr Hematol (1978); 1978 Apr; 20(1):131-7. PubMed ID: 353727
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hydantoin-induced lymphadenopathy].
    Celikic S
    Srp Arh Celok Lek; 1973 Feb; 101(2):173-7. PubMed ID: 4207031
    [No Abstract]   [Full Text] [Related]  

  • 3. Hydantoin-induced pseudo-pseudolymphoma.
    Gams RA; Neal JA; Conrad FG
    Ann Intern Med; 1968 Sep; 69(3):557-68. PubMed ID: 4970555
    [No Abstract]   [Full Text] [Related]  

  • 4. [Malignant lymphoma or hydantoin lymphadenopathy? (author's transl)].
    Beil E; Prechtel K
    Munch Med Wochenschr; 1973 Nov; 115(45):2033-9. PubMed ID: 4589193
    [No Abstract]   [Full Text] [Related]  

  • 5. [Lymphadenopathies and protein anomalies following phenylhydantoine therapy].
    Vesin P; Periac P; Kalifat R; Intrator L; Tuilliez M; Cattan D
    Nouv Presse Med; 1976 Apr; 5(17):1125-7. PubMed ID: 1084517
    [No Abstract]   [Full Text] [Related]  

  • 6. Hydantoin-induced lymphadenopathies and lymphomas.
    Rausing A
    Recent Results Cancer Res; 1978; 64():263-4. PubMed ID: 366702
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hydantoins and lymphoid neoplasms. Report of a case (author's transl)].
    Batlle Fonrodona J; Vicente Garcia V; Alberca Silva I; Corral Alonso M; Vidal Catala V; López Borrasca A
    Sangre (Barc); 1977; 22(4):486-91. PubMed ID: 408932
    [No Abstract]   [Full Text] [Related]  

  • 8. The relationship between some anticonvulsants and tumors of the blood forming organs.
    Bercel NA; Henstell HH
    Bull Los Angeles Neurol Soc; 1970 Jan; 35(1):21-4. PubMed ID: 5411538
    [No Abstract]   [Full Text] [Related]  

  • 9. [Reticular hyperplasia following hydantoin derivatives].
    Wasik F; Domanasiewicz M; Gasior B
    Hautarzt; 1975 May; 26(5):273-5. PubMed ID: 125251
    [No Abstract]   [Full Text] [Related]  

  • 10. Lymphadenopathy resulting from long-term use of hydantoin.
    Szegedi G; Krasznai G; Sorszegi P; Szabó G
    Acta Med Acad Sci Hung; 1970; 27(3):243-51. PubMed ID: 5511166
    [No Abstract]   [Full Text] [Related]  

  • 11. The diagnosis of lymphomas.
    Palmer AA
    Med J Aust; 1974 Jul; 2(3):96-8. PubMed ID: 4416161
    [No Abstract]   [Full Text] [Related]  

  • 12. Lymphangiographic findings of mesantoin-induced pseudolymphoma.
    Sayoc AS; Howland WJ
    Radiology; 1974 Jun; 111(3):579-80. PubMed ID: 4828990
    [No Abstract]   [Full Text] [Related]  

  • 13. [Malignant lymphoma following years of hydantoin treatment for epilepsy].
    Jungi WF; Senn HJ; Stanisic M; Rösli R
    Schweiz Med Wochenschr; 1975 Dec; 105(50):1735-7. PubMed ID: 1215968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pseudolymphoma syndrome].
    Leiber B; Olbrich G
    Monatsschr Kinderheilkd (1902); 1972 Sep; 120(9):398. PubMed ID: 5082810
    [No Abstract]   [Full Text] [Related]  

  • 15. [Dermatologic complications during the administration of hydantoin compounds (review)].
    Gottwald W
    Z Haut Geschlechtskr; 1969 Jul; 44(13):471-90. PubMed ID: 4243325
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hodgkin's disease following treatment with hydantoins. Report of a case and review of the literature (author's transl)].
    Bladé Creixenti J; Segura Porta F; Nogué Xarau S; Soriano Marín E; García San Miguel J
    Med Clin (Barc); 1980 Jun; 75(1):24-6. PubMed ID: 7392707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lymphadenopathies caused by drugs].
    Krasznai G; Szegedi G
    Orv Hetil; 1969 Nov; 110(48):2797-802. PubMed ID: 4903568
    [No Abstract]   [Full Text] [Related]  

  • 18. [Iatrogenic lymph node lesions (author's transl)].
    Leder LD; Lennert K
    Verh Dtsch Ges Pathol; 1972; 56():310-20. PubMed ID: 4130833
    [No Abstract]   [Full Text] [Related]  

  • 19. Generalized lymphadenopathy and nephrotic syndrome as a manifestation of mephenytoin (mesantoin) toxicity.
    Snead C; Siegel N; Hayslett J
    Pediatrics; 1976 Jan; 57(1):98-101. PubMed ID: 1246508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hypersensitivity reaction produced by the administration of mesantoin, which simulated Hodgkin's lymphoma].
    Romero García F; Reynaga Sánchez R; Wolburg López J
    Rev Invest Clin; 1967; 19(1):51-8. PubMed ID: 5317594
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.